RO103682B1 - Isolation method of human ceruloplasmin - Google Patents

Isolation method of human ceruloplasmin

Info

Publication number
RO103682B1
RO103682B1 RO137849A RO13784989A RO103682B1 RO 103682 B1 RO103682 B1 RO 103682B1 RO 137849 A RO137849 A RO 137849A RO 13784989 A RO13784989 A RO 13784989A RO 103682 B1 RO103682 B1 RO 103682B1
Authority
RO
Romania
Prior art keywords
isolation method
human ceruloplasmin
human
ceruloplasmin
chromatographing
Prior art date
Application number
RO137849A
Other languages
Romanian (ro)
Other versions
RO103682A2 (en
Inventor
Aurel Ionita
Constantina Ionita
Emil Ionita
Original Assignee
Institutul Cantacuzino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul Cantacuzino filed Critical Institutul Cantacuzino
Priority to RO137849A priority Critical patent/RO103682B1/en
Publication of RO103682A2 publication Critical patent/RO103682A2/en
Publication of RO103682B1 publication Critical patent/RO103682B1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Procedeul conform inventiei consta în aceea ca serul sau plasma umana se trateaza cu solutie CuSO4 1 M (100:0,4) si apoi se mentine la 68 degree C, timp de 30 min, se centrifugheaza, se cromatografiaza întâi pe DEAE-Sepharose CL-68 în tampon 0,02 M pirofosfat de sodiu - acid acetic pH=7,5 si apoi pe Cibacron - Blue F3GA - Bio_gel A5 m în TFS 0,05 M pH=7.The process according to the invention consists in treating the human serum or plasma with 1 M CuSO4 solution (100: 0.4) and then at 68 DEG C. for 30 minutes, centrifuging, first chromatographing on DEAE-Sepharose CL -68 in buffer 0.02 M sodium pyrophosphate-acetic acid pH = 7.5 and then Cibacron-Blue F3GA-Bio_gel A5 m in TMS 0.05 M pH = 7.

RO137849A 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin RO103682B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO137849A RO103682B1 (en) 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO137849A RO103682B1 (en) 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin

Publications (2)

Publication Number Publication Date
RO103682A2 RO103682A2 (en) 1991-12-09
RO103682B1 true RO103682B1 (en) 1992-03-26

Family

ID=20123823

Family Applications (1)

Application Number Title Priority Date Filing Date
RO137849A RO103682B1 (en) 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin

Country Status (1)

Country Link
RO (1) RO103682B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition

Also Published As

Publication number Publication date
RO103682A2 (en) 1991-12-09

Similar Documents

Publication Publication Date Title
RO90639B (en) Process for preparing a human tissue plasminogene activator
FI871288A0 (en) Process for Preparation of Aprotinin by Recombinant DNA Technology and in the Method Useful DNA, Expression Plasmid and Host Cell
FI880464A0 (en) BEKAEMPNINGSMEDEL MOT TANDPLAQUE OCH -KARIES.
EA200000563A1 (en) METHODS OF TREATMENT OF WOMEN IN POST-CLIMACTERISTIC CONDITION WITH THE USE OF ULTRANIZED ESTROGEN DOSES
MY118591A (en) Improved methods for processing activated protein c
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
EP0254289A3 (en) Agent for the treatment of arthrosis
HUT56133A (en) Process for treating viral infections with functional derivatives of icam-1 intercellular adhesion molecule
SE8703225L (en) MONOCLONAL ANTIBODIES AND PEPTIDES USEFUL IN TREATMENT AND DIAGNOSTIZATION OF HIV INFECTIONS
SG48298A1 (en) Saccharin deriatives useful as proteolytic enzymeinhibitors and preparation of
ZA837506B (en) A process for the pasteurization of antihemophilic cryoprecipitate(ahc),and antihemophilic cryoprecipitate prepared thereby
ES8503238A1 (en) Process for the preparation of protein concentrates and nutriments by processing animal blood
ES2072490T3 (en) PROCEDURE FOR PASTEURIZATION OF TISSUE PROTEIN PP4.
AU561222B2 (en) Process for the pasteurization of human plasma
RO103682B1 (en) Isolation method of human ceruloplasmin
AU539210B2 (en) Protein ppg, its isolation and use
FI883450A0 (en) A method for purifying placental tissue protein PP4
DE69033587D1 (en) TOPICAL TREATMENT OF BLEPHARITIS
EP0120835A3 (en) Process for the inactivation of incompatibility inducing substances
EA200100385A1 (en) COMPOSITION AND METHOD OF TREATMENT OF HEMOSTASIS DISORDER IN THE SUBJECT (OPTIONS)
AU5476598A (en) Method of obtaining haemin from slaughter blood
EP0321094A3 (en) Treatment of factor viii inhibitors
EP0241000A3 (en) Method for determination of complements
RO98811B1 (en) Process for obtaining some bacillus-type micro-disks
UA23098A (en) Method for preparation of morphological preparations for immune-cytochemical study